JP2022546609A5 - - Google Patents
Info
- Publication number
- JP2022546609A5 JP2022546609A5 JP2022514998A JP2022514998A JP2022546609A5 JP 2022546609 A5 JP2022546609 A5 JP 2022546609A5 JP 2022514998 A JP2022514998 A JP 2022514998A JP 2022514998 A JP2022514998 A JP 2022514998A JP 2022546609 A5 JP2022546609 A5 JP 2022546609A5
- Authority
- JP
- Japan
- Prior art keywords
- composite
- seq
- complex
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025065195A JP2025108559A (ja) | 2019-09-06 | 2025-04-10 | ウイルス感染症の治療のための組成物及び方法 |
Applications Claiming Priority (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962897036P | 2019-09-06 | 2019-09-06 | |
| US62/897,036 | 2019-09-06 | ||
| US201962941405P | 2019-11-27 | 2019-11-27 | |
| US62/941,405 | 2019-11-27 | ||
| US201962948143P | 2019-12-13 | 2019-12-13 | |
| US62/948,143 | 2019-12-13 | ||
| US202062959857P | 2020-01-10 | 2020-01-10 | |
| US62/959,857 | 2020-01-10 | ||
| US202062966500P | 2020-01-27 | 2020-01-27 | |
| US62/966,500 | 2020-01-27 | ||
| US202062970491P | 2020-02-05 | 2020-02-05 | |
| US62/970,491 | 2020-02-05 | ||
| US202062984705P | 2020-03-03 | 2020-03-03 | |
| US62/984,705 | 2020-03-03 | ||
| US202062988304P | 2020-03-11 | 2020-03-11 | |
| US62/988,304 | 2020-03-11 | ||
| US202063032488P | 2020-05-29 | 2020-05-29 | |
| US63/032,488 | 2020-05-29 | ||
| US202063062377P | 2020-08-06 | 2020-08-06 | |
| US63/062,377 | 2020-08-06 | ||
| PCT/US2020/049772 WO2021046549A1 (en) | 2019-09-06 | 2020-09-08 | Compositions and methods for the treatment of viral infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025065195A Division JP2025108559A (ja) | 2019-09-06 | 2025-04-10 | ウイルス感染症の治療のための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546609A JP2022546609A (ja) | 2022-11-04 |
| JP2022546609A5 true JP2022546609A5 (cg-RX-API-DMAC7.html) | 2023-09-15 |
| JP7667139B2 JP7667139B2 (ja) | 2025-04-22 |
Family
ID=74852729
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514998A Active JP7667139B2 (ja) | 2019-09-06 | 2020-09-08 | ウイルス感染症の治療のための組成物及び方法 |
| JP2025065195A Pending JP2025108559A (ja) | 2019-09-06 | 2025-04-10 | ウイルス感染症の治療のための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025065195A Pending JP2025108559A (ja) | 2019-09-06 | 2025-04-10 | ウイルス感染症の治療のための組成物及び方法 |
Country Status (18)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210079278A (ko) | 2018-09-06 | 2021-06-29 | 시다라 세라퓨틱스, 인코포레이티드 | 바이러스 감염의 치료를 위한 조성물 및 방법 |
| TWI861205B (zh) | 2019-09-06 | 2024-11-11 | 美商席達拉醫療有限公司 | 用於治療病毒感染之組合物及方法 |
| MX2022008901A (es) * | 2020-01-24 | 2022-08-16 | Regeneron Pharma | Conjugados de proteinas-compuestos antivirales. |
| US20230364251A1 (en) | 2020-08-06 | 2023-11-16 | Cidara Therapeutics, Inc. | Methods for the synthesis of protein-drug conjugates |
| CN116367866A (zh) | 2020-08-06 | 2023-06-30 | 奇达拉治疗公司 | 蛋白质-药物偶联物的合成方法 |
| WO2022192685A1 (en) | 2021-03-11 | 2022-09-15 | Cidara Therapeutics, Inc. | Protein-drug conjugates for antiviral therapy |
| CN118678970A (zh) * | 2021-12-30 | 2024-09-20 | 苏州爱科百发生物医药技术有限公司 | 用于预防和治疗病毒感染的偶联物及其用途 |
| CA3261323A1 (en) * | 2022-07-05 | 2024-01-11 | Cidara Therapeutics, Inc. | FC CONJUGATES INCLUDING A CD73 INHIBITOR AND THEIR USES |
| CN119215189A (zh) | 2023-06-29 | 2024-12-31 | 上海爱科百发生物医药技术股份有限公司 | 用于预防和治疗病毒感染的偶联物及其用途 |
| WO2025064869A2 (en) * | 2023-09-20 | 2025-03-27 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of cancer |
| IL328897A (en) * | 2023-12-08 | 2026-08-01 | Suzhou Renolynx Therapeutics Co Ltd | Antiviral bracelet |
| WO2025157263A1 (zh) * | 2024-01-26 | 2025-07-31 | 浙江养生堂天然药物研究所有限公司 | 偶联物及其制备方法和用途 |
| WO2025230581A1 (en) * | 2024-05-02 | 2025-11-06 | Cidara Therapeutics, Inc. | Fc conjugates and uses thereof |
| WO2026055183A1 (en) * | 2024-09-03 | 2026-03-12 | Vir Biotechnology, Inc | Antiviral compositions and methods of using the same |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000068986A (ko) | 1996-11-14 | 2000-11-25 | 리차드웨드레이 | 신규 용도 화합물 및 그 제조방법 |
| US6495580B1 (en) | 1998-01-29 | 2002-12-17 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| AUPP913999A0 (en) | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| EP1418175A1 (en) | 1999-06-28 | 2004-05-12 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
| AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879701A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| US8202896B2 (en) | 2002-08-09 | 2012-06-19 | Microdose Therapeutx, Inc. | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| CA2556752C (en) | 2004-02-23 | 2016-02-02 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| RU2470668C2 (ru) | 2005-08-19 | 2012-12-27 | Эндосайт, Инк. | Конъюгаты лиганда с несколькими лекарственными средствами |
| MX2009012343A (es) | 2007-05-14 | 2010-02-10 | Biogen Idec Inc | Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello. |
| JP2012517447A (ja) | 2009-02-10 | 2012-08-02 | ザ スクリプス リサーチ インスティチュート | 化学的にプログラムされたワクチン接種法 |
| DK2568976T3 (en) | 2010-05-10 | 2016-01-11 | Academia Sinica | Zanamivir-phosphonate congener with the anti-influenza activity, and determining the sensitivity oseltamivir in influenza viruses |
| CN102958933B (zh) | 2010-06-24 | 2016-02-03 | 吉里德科学公司 | 作为抗病毒药的吡唑并[1,5-a]嘧啶类 |
| EP3415528B1 (en) | 2011-04-13 | 2021-05-26 | Bristol-Myers Squibb Company | Fc fusion proteins comprising novel linkers or arrangements |
| US8871756B2 (en) | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
| TW201817745A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
| WO2014047357A1 (en) | 2012-09-21 | 2014-03-27 | The Regents Of The University Of California | Modified fc polypeptides, fc conjugates, and methods of use thereof |
| AU2013334001B2 (en) | 2012-10-16 | 2017-07-20 | Janssen Sciences Ireland Uc | RSV antiviral compounds |
| PL2970422T3 (pl) | 2013-03-15 | 2018-09-28 | F.Hoffmann-La Roche Ag | Polipeptydy IL-22 i białka fuzyjne IL-22 Fc i sposoby zastosowania |
| AR096891A1 (es) | 2013-07-12 | 2016-02-03 | Hanmi Pharm Ind Co Ltd | Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo |
| MX2016001855A (es) | 2013-08-12 | 2016-05-24 | Hoffmann La Roche | Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio. |
| TWI671299B (zh) | 2014-04-14 | 2019-09-11 | 愛爾蘭商健生科學愛爾蘭無限公司 | 作為rsv抗病毒化合物之螺脲化合物 |
| WO2017046625A1 (en) | 2015-06-25 | 2017-03-23 | Cube Biotech Gmbh | New chelators for affinity purification of recombinant proteins |
| WO2018006063A1 (en) | 2016-07-01 | 2018-01-04 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of bacterial infections |
| US20230190950A1 (en) * | 2017-01-06 | 2023-06-22 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of bacterial infections |
| KR20210079278A (ko) | 2018-09-06 | 2021-06-29 | 시다라 세라퓨틱스, 인코포레이티드 | 바이러스 감염의 치료를 위한 조성물 및 방법 |
| EP3982994A4 (en) | 2019-06-13 | 2023-10-04 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of respiratory syncytial virus |
| CN114401731A (zh) | 2019-06-13 | 2022-04-26 | 奇达拉治疗公司 | 用于治疗人类免疫缺陷病毒的组合物及方法 |
| TWI861205B (zh) * | 2019-09-06 | 2024-11-11 | 美商席達拉醫療有限公司 | 用於治療病毒感染之組合物及方法 |
| WO2022192685A1 (en) * | 2021-03-11 | 2022-09-15 | Cidara Therapeutics, Inc. | Protein-drug conjugates for antiviral therapy |
-
2020
- 2020-09-07 TW TW109130663A patent/TWI861205B/zh active
- 2020-09-08 CN CN202080077368.1A patent/CN114980933B/zh active Active
- 2020-09-08 PH PH1/2022/550505A patent/PH12022550505A1/en unknown
- 2020-09-08 WO PCT/US2020/049772 patent/WO2021046549A1/en not_active Ceased
- 2020-09-08 EP EP20860243.3A patent/EP4025256A4/en active Pending
- 2020-09-08 CN CN202510048861.5A patent/CN120168655A/zh active Pending
- 2020-09-08 KR KR1020227011190A patent/KR20220088527A/ko active Pending
- 2020-09-08 CR CR20220138A patent/CR20220138A/es unknown
- 2020-09-08 AU AU2020342649A patent/AU2020342649B2/en active Active
- 2020-09-08 PE PE2022000373A patent/PE20221443A1/es unknown
- 2020-09-08 CA CA3153359A patent/CA3153359A1/en active Pending
- 2020-09-08 MX MX2022002728A patent/MX2022002728A/es unknown
- 2020-09-08 JP JP2022514998A patent/JP7667139B2/ja active Active
-
2021
- 2021-03-05 US US17/194,093 patent/US20210220478A1/en not_active Abandoned
- 2021-04-21 US US17/236,745 patent/US11510992B1/en active Active
-
2022
- 2022-02-22 IL IL290792A patent/IL290792B2/en unknown
- 2022-03-03 CL CL2022000531A patent/CL2022000531A1/es unknown
- 2022-03-17 CO CONC2022/0003078A patent/CO2022003078A2/es unknown
- 2022-03-30 ZA ZA2022/03681A patent/ZA202203681B/en unknown
- 2022-04-05 EC ECSENADI202226797A patent/ECSP22026797A/es unknown
- 2022-08-15 US US17/887,776 patent/US12427200B2/en active Active
-
2025
- 2025-04-10 JP JP2025065195A patent/JP2025108559A/ja active Pending
- 2025-07-23 US US19/277,976 patent/US20260108618A1/en active Pending
- 2025-11-07 AU AU2025263868A patent/AU2025263868A1/en active Pending